secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xtant Medical Holdings, Inc. (XTNT)
CIK:        0001453593
Form:       8-K
Filed at:   2024-09-03T23:59:59+00:00
Accession:  0001493152-24-034813
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Xtant files updated Surgalign historical financials in support of S-3 registration
--------------------------------------------------------------------------------

- Filing includes Surgalign's unaudited financials for H1 2023 and FY2022, and pro forma combined data for FY2023.
- Surgalign H1 2023 revenue $30.3M (down from $41.2M); net income $5.8M vs loss $5.7M, driven by Coflex sale and warrant liability changes.
- Pro forma info is presented for informational purposes and does not project future results.
- No current operational update or guidance for Xtant is provided in this filing.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1453593/000149315224034813/0001493152-24-034813-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1453593/000149315224034813/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-034813

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer